{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T14:38:25Z","timestamp":1776782305732,"version":"3.51.2"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.radonc.2022.02.033","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T11:19:03Z","timestamp":1646392743000},"page":"118-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Pre-OPerative accelerated radiotherapy for early stage breast cancer patients (POPART): A feasibility study"],"prefix":"10.1016","volume":"170","author":[{"given":"Thomas","family":"Mulliez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geertje","family":"Miedema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilde","family":"Van Parijs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Hottat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maud","family":"Vassilieff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evy","family":"Gillet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Baeyens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mia","family":"Voordeckers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolien","family":"Coelmont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana","family":"Besse-Hammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Gevaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Nazac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"De Ridder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2022.02.033_b0005","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","article-title":"Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials","volume":"378","author":"Early Breast Cancer Trialists' Collaborative G","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2022.02.033_b0010","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c845","article-title":"Impact of interval from breast conserving surgery to radiotherapy on local recurrence in older women with breast cancer: retrospective cohort analysis","volume":"340","author":"Punglia","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.radonc.2022.02.033_b0015","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.radonc.2013.10.033","article-title":"Target volume delineation in external beam partial breast irradiation: less inter-observer variation with preoperative- compared to postoperative delineation","volume":"110","author":"van der Leij","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.02.033_b0020","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa0906260","article-title":"Long-term results of hypofractionated radiation therapy for breast cancer","volume":"362","author":"Whelan","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2022.02.033_b0025","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1748-717X-7-80","article-title":"Short course radiotherapy with simultaneous integrated boost for stage I-II breast cancer, early toxicities of a randomized clinical trial","volume":"7","author":"Van Parijs","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.02.033_b0030","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1186\/1471-2407-12-495","article-title":"Health-related quality of life in survivors of stage I-II breast cancer: randomized trial of post-operative conventional radiotherapy and hypofractionated tomotherapy","volume":"12","author":"Versmessen","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2022.02.033_b0035","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"395","author":"Murray Brunt","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2022.02.033_b0040","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.amjsurg.2020.02.061","article-title":"Surgical timing following neoadjuvant chemotherapy for breast cancer affects postoperative complication rates","volume":"219","author":"Sutton","year":"2020","journal-title":"Am J Surg"},{"key":"10.1016\/j.radonc.2022.02.033_b0045","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1470-2045(17)30777-5","article-title":"Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials","volume":"19","author":"Early Breast Cancer Trialists' Collaborative G","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2022.02.033_b0050","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ijrobp.2008.01.039","article-title":"Locoregional treatment outcomes after multimodality management of inflammatory breast cancer","volume":"72","author":"Bristol","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.02.033_b0055","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.radonc.2015.02.002","article-title":"First results of the preoperative accelerated partial breast irradiation (PAPBI) trial","volume":"114","author":"van der Leij","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.02.033_b0060","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.ijrobp.2019.12.037","article-title":"Five-year results of the preoperative accelerated partial breast irradiation (PAPBI) trial","volume":"106","author":"Bosma","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.02.033_b0065","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ijrobp.2016.11.030","article-title":"Preoperative accelerated partial breast irradiation for early-stage breast cancer: preliminary results of a prospective, phase 2 trial","volume":"97","author":"Nichols","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.02.033_b0070","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.surg.2012.05.001","article-title":"Impact of neoadjuvant chemotherapy on wound complications after breast surgery","volume":"152","author":"Decker","year":"2012","journal-title":"Surgery"},{"key":"10.1016\/j.radonc.2022.02.033_b0075","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ajic.2009.02.010","article-title":"Surveillance, control, and prevention of surgical site infections in breast cancer surgery: a 5-year experience","volume":"37","author":"Vilar-Compte","year":"2009","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.radonc.2022.02.033_b0080","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40001-016-0219-8","article-title":"Breast reconstruction after neoadjuvant radio chemotherapy: review and personal technique IDEAL concept REV-EJMR-D-15-00268","volume":"21","author":"Nestle-Kramling","year":"2016","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.radonc.2022.02.033_b0085","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000355196","article-title":"Final results of a safety and efficacy trial of preoperative sequential chemoradiation therapy for the nonsurgical treatment of early breast cancer: Japan Clinical Oncology Group Study JCOG0306","volume":"85","author":"Mukai","year":"2013","journal-title":"Oncology"},{"key":"10.1016\/j.radonc.2022.02.033_b0090","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ijc.1024","article-title":"Long-term results of neoadjuvant radiation therapy for breast cancer","volume":"96","author":"Calitchi","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.radonc.2022.02.033_b0095","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.radonc.2016.02.027","article-title":"Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial","volume":"120","author":"Brunt","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.02.033_b0100","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00066-010-2143-0","article-title":"Retrospective study of neoadjuvant versus adjuvant radiochemotherapy in locally advanced noninflammatory breast cancer: survival advantage in cT2 category by neoadjuvant radiochemotherapy","volume":"186","author":"Roth","year":"2010","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2022.02.033_b0105","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0167-8140(93)90090-U","article-title":"Adjuvant radiation therapy versus surgery alone in operable breast cancer: long-term follow-up of a randomized clinical trial","volume":"26","author":"Rutqvist","year":"1993","journal-title":"Radiother Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814022001177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814022001177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:21:00Z","timestamp":1759123260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814022001177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":21,"alternative-id":["S0167814022001177"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2022.02.033","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre-OPerative accelerated radiotherapy for early stage breast cancer patients (POPART): A feasibility study","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2022.02.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}